Lee; Ge Hyeong

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lee; Ge Hyeong.The latest application filed is for "heteroaryl derivative or pharmaceutically acceptable salt thereof, preparation method therefor, and pharmaceutical compostion for preventing or treating diseases associated with pi3 kinases, containing same as active ingredient".

Company Profile

1.4.3

Lee; Ge Hyeong - Daejeon KR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Heteroaryl derivative or pharmaceutically acceptable salt thereof, preparation method therefor, and pharmaceutical composition for preventing or treating diseases associated with PI3 kinases, containing same as active ingredient Grant 10,526,337 - Lee , et al. J	2020-01-07
Heteroaryl Derivative Or Pharmaceutically Acceptable Salt Thereof, Preparation Method Therefor, And Pharmaceutical Compostion For Preventing Or Treating Diseases Associated With Pi3 Kinases, Containing Same As Active Ingredient App 20180105527 - Lee; Ge Hyeong ; et al.	2018-04-19
8-oxoprotoberberine derivative or pharmaceutically acceptable salt thereof, preparation method therefor and pharmaceutical composition for preventing or treating diseases associated with activity of NFAT5, containing same as active ingredient Grant 9,650,389 - Cho , et al. May 16, 2	2017-05-16
Fused ring compound containing furan or salt thereof and pharmaceutical composition comprising same Grant 9,493,478 - Seo , et al. November 15, 2	2016-11-15
Novel 8-Oxoprotoberberine Derivative or Pharmaceutically Acceptable Salt Thereof, Preparation Method Therefor and Pharmaceutical Composition for Preventing or Treating Diseases Associated with Activity of NFAT5, Containing Same as Active Ingredient App 20160251368 - CHO; Heeyeong ; et al.	2016-09-01
Fused Ring Compound Containing Furan Or Salt Thereof And Pharmaceutical Composition Comprising Same App 20150191478 - Seo; Hyoung Sig ; et al.	2015-07-09
5-(1,3-Diaryl-1H-pyrazol-4-ylmethylene)-thiazolidine,2,4-dione derivatives useful as anticancer agent Grant 7,718,681 - Kim , et al. May 18, 2	2010-05-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.